Johnson & Johnson said Friday that the worldwide president of its DePuy Orthopaedics division, a maker of artificial hips and knees that has struggled with product recalls and lawsuits over faulty implants, is leaving the company. The executive, David Floyd, submitted his resignation last week and will leave at the end of March, a spokeswoman said. He had been president of the unit since 2007. He is leaving to pursue interests outside the company, the spokesman, Lorie Gawreluk, said, declining to be more specific. DePuy recalled the ASR XL Acetabular hip system last August, after researchers found 13 percent of patients needed a repeat operation to fix problems with the implant. The company took a $280 million charge in the fourth quarter to pay for the recall. The company faces more than 500 lawsuits by patients who had the hip implants.
Global Medical Equipment Markets 2017-2022 – Market is Expected to Reach Over $500 Billion in 2020 – Research and Markets
- The single protein injection which could replace the need for knee surgery for osteoarthritis sufferers 72 comments
- Pegasus Biologics is insolvent; Closing their doors 40 comments
- THE SPINEBLOGGER 17 comments
- NuVasive CEO: No Sign Of Economic Hit To Spinal Devices 8 comments
- Win an iPod Shuffle 6 comments
Subscribe to Blog via Email